Leslie Rickey, MD
Urology · New Haven, CTNPI 1396930079
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,850 of the $17,091 with a category attached, or 86.9%. 8 manufacturers reported payments, led by GSK at 54.6% of the total. 2025 is the largest year on record at $9,755, 2.1 times the $4,566 reported in 2019.
Across 29 payments — averaging $589.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$9K
- Urocure LLC$6K
- Boston Scientific$730
- Renovia Inc$600
- AbbVie$412
- Medtronic$339
- plus $75 from 2 others
What the payments were for
- Consulting fees$14,85087%
- Travel & lodging$7474%
- Food & beverage$1,4949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $9,330 |
| Urocure LLC | 7 | $5,605 |
| Boston Scientific | 6 | $730 |
| Renovia Inc | 2 | $600 |
| AbbVie(2 entities) | 3 | $412 |
| Medtronic | 4 | $339 |
| Applied Medical Resources Corporation | 1 | $53 |
| Baxter Healthcare | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leva Pelvic Floor Trainer$600
- BOTOX$399
- Solyx SIS System$266
- INTERSTIM$150
- GENERAL PELVIC ORGAN PROLAPSE$111
- Axonics$100
How this compares
$17,091 in reported general payments places this provider in the 85th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 27 | $16,710 |
| MyrbetriqMirabegron | 12 | $6,267 |
| Estradiol | 51 | $2,594 |
Paid to pharmacies, not to this prescriber.
Other urology in New Haven
- Daniel KellnerNew Haven$122K
- Preston SprenkleNew Haven$57K
- Stanton HonigNew Haven$40K
- Michael LeapmanNew Haven$21K
- Jason LeeNew Haven$19K
- Gregory LacyNew Haven$11K
- Fady GhaliNew Haven$10K
- Guy ManettiNew Haven$7K
- Wei Shen TanNew Haven$6K
- Ganesh SanekommuNew Haven$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.